Delivery Order SPE2DB20D1047-SPE2DB24FF89K
Award Date
9/23/24
Potential Completion Date
9/24/24
Potential Value
$1.5K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lamotrigine ER 100 mg tablets. The contract has a firm fixed price of $9,108.60 and a completion date of June 4, 2025. The contract is not set-aside and represents an open competition. AmerisourceBergen Drug Corp is the prime contractor for this delivery order, which is part of a larger $999,999,999.00 Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distribution and healthcare solutions provider. The contract is for the delivery of Lamotrigine ER 200 mg tablets in quantities of 30, with a ceiling value of $1,573.30 and a final completion date of June 23, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen...
This contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp to provide Lamotrigine ER 50 mg tablets. The award is a Delivery Order issued under a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a wide range of pharmaceutical and medical supplies from AmerisourceBergen to support military healthcare programs and facilities worldwide....
This is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $2,248.34, is for the supply of Lamotrigine ER 50 mg tablets. It is a firm fixed-price contract with a completion date of June 10, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the drug Lamotrigine ER 100 mg tablets. The contract has a firm fixed price and a ceiling value of $4,103.24. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Lamotrigine ER 50 mg tablets to the Defense Logistics Agency (DLA). The contract has a ceiling value of $6,896.92 and runs through April 30, 2024. It is a firm-fixed-price delivery order contract, with no set-aside designation. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Lamotrigine ER 300 mg tablets and has a ceiling value of $4,162.80. The contract is a firm fixed-price delivery order with a period of performance through March 6, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Lamotrigine ER 50 mg tablets, a medication used to treat certain types of seizures. The contract has a ceiling value of $2,902.11 and a period of performance through May 3, 2023. The contract is a firm-fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lamotrigine ER 50 mg tablets, a medication used to treat mental health conditions. The total ceiling value of the contract is $7,532.02, and it is a Firm Fixed Price Delivery Order type contract that runs through February 12, 2025. The contract does not have a set-aside designation,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lamotrigine ODT 50 mg tablets, a medication used to treat certain types of seizures. The contract has a ceiling value of $20,267.48 and is a firm fixed-price, non-set-aside contract with a period of performance through May 9, 2025. AmerisourceBergen holds a significant Indefinite...